Open-Angle Glaucoma Treatment in Kyle

Open-angle glaucoma is a chronic, lifelong condition that requires ongoing management rather than a finite treatment course. Once diagnosed, you'll need to use prescribed eye drops daily—typically once or twice per day—for the rest of your life to maintain safe eye pressure levels. Follow-up appointments are scheduled every 3-6 months indefinitely to monitor disease stability. While this may sound daunting, most patients find that daily eye drops become a simple routine, similar to taking blood pressure medication. The good news is that with consistent treatment, the vast majority of patients never experience significant vision loss. Treatment is highly effective at preserving vision when followed as prescribed.

For the vast majority of open-angle glaucoma patients, prescription eye drops are the first-line treatment and are highly effective at lowering intraocular pressure. In very early cases or those with borderline pressures and low risk factors, your doctor may recommend close observation initially without medication—called "glaucoma suspect" monitoring. However, once diagnosis is confirmed and treatment is needed, medication is nearly always required. Some patients who cannot tolerate drops or don't achieve adequate pressure control may undergo laser trabeculoplasty, which can reduce or eliminate the need for some medications. Surgical procedures are reserved for advanced cases or medication failures. There are no proven dietary supplements or lifestyle changes that can replace medical treatment, though exercise, healthy diet, and avoiding smoking support overall eye health.

Yes, glaucoma diagnosis and treatment are considered medically necessary and are covered by virtually all health insurance plans, including Medicare and Medicaid. Office visits, diagnostic testing (visual fields, OCT imaging), and examinations are typically covered under your medical insurance—not vision insurance—since glaucoma is a medical eye disease. Prescription eye drop medications are covered under your pharmacy benefit, though copays vary and brand-name drugs may require prior authorization or step therapy. Many effective generic glaucoma medications are now available at lower cost. If cost is a concern, let us know—we can often prescribe equally effective generic alternatives or help you access manufacturer patient assistance programs. Laser and surgical treatments, when necessary, are also covered by medical insurance.

If your eye pressure remains elevated despite medication or if visual field testing shows progressive vision loss, we have multiple options to intensify treatment. First, we may add a second or third medication class, as many patients require combination therapy for adequate pressure control. Fixed-combination eye drops that contain two medications in one bottle can improve convenience and adherence. If medications are insufficient, poorly tolerated, or you're already on maximal therapy, we'll coordinate referral for selective laser trabeculoplasty (SLT), a safe, in-office procedure that improves drainage and often reduces medication needs. For advanced or refractory glaucoma, surgical options including trabeculectomy, tube shunt implantation, or minimally invasive glaucoma surgery (MIGS) may be necessary. Throughout this process, we maintain close collaboration with glaucoma specialists while continuing to monitor your progress and support your overall eye health.

Telehealth can play a valuable supplementary role in glaucoma management, though it cannot fully replace in-person examinations. Comprehensive glaucoma evaluations require specialized equipment to measure eye pressure, examine the optic nerve, and perform visual field testing—all of which must be done in the office. However, telehealth is excellent for medication reviews, discussing side effects, answering treatment questions, reviewing recent test results, providing education about your condition, and addressing adherence challenges between scheduled office visits. We may also use telehealth for follow-up consultations after medication changes to assess your response and tolerance before the next in-person examination. This hybrid approach increases access to care, reduces travel burden, and helps ensure continuous engagement with your treatment plan while maintaining the essential hands-on monitoring that glaucoma requires.

The vast majority of patients with open-angle glaucoma who receive appropriate treatment and follow their prescribed care plan do not go blind. Studies show that with early detection and consistent treatment, more than 90% of glaucoma patients maintain functional vision throughout their lifetime. The key factors that determine outcomes are early diagnosis (through regular eye exams), medication adherence, and regular monitoring to detect progression early. Patients who use their drops as prescribed, attend follow-up appointments, and work with their eye care team to adjust treatment when needed have excellent visual prognoses. The patients most at risk for significant vision loss are those diagnosed late with advanced damage already present, those who don't use their medications consistently, or those who don't follow up regularly. This is why we emphasize patient education, provide adherence support, and maintain frequent communication—because we're committed to preserving your vision for life.